openPR Logo
Press release

Bispecific Antibodies Market Industry Share, Growth, Development and Demand Forecast to 2029

11-08-2023 08:40 AM CET | Health & Medicine

Press release from: MAXIMIZE MARKET RESEARCH PVT. LTD.

Bispecific Antibodies Market

Bispecific Antibodies Market

The Global Bispecific Antibodies Market has witnessed remarkable growth, marked by its value of USD 0.54 billion in 2022 and a projected surge to USD 0.89 billion by 2029, boasting a notable Compound Annual Growth Rate (CAGR) of 7.39%. Bispecific antibodies, a unique class of therapeutic agents capable of simultaneously targeting two different entities, are at the forefront of the pharmaceutical landscape. This exceptional growth can be attributed to multiple factors, creating a promising landscape for the bispecific antibodies market.

Bispecific Antibodies Market Overview

Bispecific antibodies have taken the pharmaceutical world by storm, offering a versatile approach to target multiple entities simultaneously. Their therapeutic applications are far-reaching, making them a valuable asset in the fight against various diseases. The market's robust growth is primarily driven by the rising prevalence of cancer and other medical conditions, a growing demand for personalized medicine, and notable advancements in bispecific antibody technology. Furthermore, ongoing clinical trials conducted by numerous pharmaceutical companies are expected to fuel the market's expansion.

Bispecific Antibodies Market Scope and Research Methodology

The comprehensive market report provides valuable insights into the bispecific antibodies market, delving into key parameters such as Indication, End-User, Drug Type, distribution channel, and geographical region. It offers a detailed market overview, highlighting trends, drivers, restraints, opportunities, and challenges that shape the bispecific antibodies industry.

The market segments are structured around Indications, encompassing Autoimmune Diseases and Oncology, End-Users like Hospitals, Speciality Clinics, and Homecare, Drug Types including Blinatumomab, Catumaxomab, and Duligotumab, and distribution channels featuring Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy.

Know More About The Report:

https://www.maximizemarketresearch.com/market-report/bispecific-antibodies-market/217462/

Bispecific Antibodies Market Dynamics

Key Drivers for Growth of Bispecific Antibodies Market

Growing Incidence of Cancer and Other Diseases: The rising global prevalence of cancer and other diseases is fueling the demand for innovative therapy alternatives. Bispecific antibodies offer a promising approach for specialized treatments, with cancer cases expected to dominate the market share, reaching up to 48% by 2029.

Research and Diagnostics Advances: Advances in biomedical research, particularly in genomics, proteomics, and cell biology, have elevated the demand for bispecific antibodies. These antibodies play a pivotal role in understanding diseases, identifying therapeutic targets, and unraveling disease mechanisms.

Market Trends

Technology Advancements: Continuous research and development efforts have significantly improved the technology for bispecific antibodies. These advancements enhance their effectiveness and safety profile, contributing to their widespread adoption. Modern protein engineering techniques allow the creation of molecules that can bind to multiple unique targets, offering more control over complex disease pathways.

Bispecific Antibodies Market Segmental Analysis:

Indication: Oncology is projected to dominate the market, contributing to 60% of the total share by 2029.

End-User: Hospitals are expected to hold the largest share, comprising approximately 49% during the forecast period.

Drug Type: Blinatumomab, a medication used in the treatment of acute lymphoblastic leukemia, is set to be the most profitable class in the bispecific antibodies market.

Distribution Channel: Hospital Pharmacies are anticipated to be the largest during the period 2022-2029.

Please connect with our representative, who will ensure you to get a report sample here @ :

https://www.maximizemarketresearch.com/request-sample/217462

Who are Bispecific Antibodies Market Key Players?

1. F. Hoffmann-La Rocha Ltd.,
2. GenScript Inc.,
3. Sino Biological LLC,
4. Creative-Biologics Inc.,
5. Bristol-Myer Squibb Co. Inc.,
6. Biotogenics Ltd.,
7. Biocytec Enzymes, Inc.,
8. Amgen, Inc., Pfizer, Inc.,
9. Novartis AG
10. Johnson & Johnson
11. Protogenix Inc.
12. GSK plc.
13. Sanofi
14. Regeneron Pharmaceuticals Inc.
15. Pfizer Inc.
16. Johnson & Johnson Services Inc.
17. Novartis AG
18. CELGENE CORPORATION[VG1]
19. Amgen
20. Roche
21. Genentech
22. Akeso, Inc.
23. Janssen
24. Taisho Pharmaceutical

Table of content for the Bispecific Antibodies Market includes:

Part 01: Executive Summary

Part 02: Scope of the Bispecific Antibodies Market Report

Part 03: Bispecific Antibodies Market Landscape

Part 04: Bispecific Antibodies Market Sizing

Part 05: Bispecific Antibodies Market Segmentation by Type

Part 06: Five Forces Analysis

Part 07: Customer Landscape

Part 08: Geographic Landscape

Part 09: Decision Framework

Part 10: Drivers and Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

For more Information Click Here @ :

https://www.maximizemarketresearch.com/request-sample/217462

Regional Insights

The market is led by North America, with the US playing a pivotal role. The European market also enjoys a significant share, benefiting from a strong healthcare system and a supportive regulatory framework. The Asia-Pacific region holds untapped opportunities, with a growing healthcare system and an emerging market for bispecific antibody therapeutics.

Contact Maximize Market Research:

3rd Floor, Navale IT Park, Phase 2

Pune Banglore Highway, Narhe,

Pune, Maharashtra 411041, India

sales@maximizemarketresearch.com

+91 96071 95908, +91 9607365656

About Maximize Market Research:

Maximize Market Research is a swiftly growing enterprise that specializes in market research and corporate advisory services, serving clients globally. With our substantial impact on revenue and unwavering commitment to research excellence, we have positioned ourselves as a trusted partner to a significant portion of Fortune 500 companies. Our comprehensive range of services caters to a diverse array of industries, including but not limited to IT, telecommunications, chemicals, food and beverages, aerospace and defense, healthcare, and beyond.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bispecific Antibodies Market Industry Share, Growth, Development and Demand Forecast to 2029 here

News-ID: 3280280 • Views:

More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.

Courier Services Market Set to Surge to USD 712 Billion by 2032 with a 5.8% CAGR
Courier Services Market Set to Surge to USD 712 Billion by 2032 with a 5.8% CAGR
The Courier Services Market size was valued at USD 453.56 Billion in 2024 and the total Courier Services revenue is expected to grow at a CAGR of 5.8% from 2025 to 2032, reaching nearly USD 712.07 Billion. Courier Services Market Overview The global Courier Services Market has experienced significant growth, driven by the rising adoption of e-commerce, growing Internet penetration, and changing consumer lifestyles. Courier services provide quick, door-to-door delivery solutions for
WealthTech Solutions Market Set to Triple by 2030 with a Robust 15.58% CAGR
WealthTech Solutions Market Set to Triple by 2030 with a Robust 15.58% CAGR
WealthTech Solutions Market was valued at USD 6.47 Billion in 2023, and it is expected to reach USD 17.83 Billion by 2030, exhibiting a CAGR of 15.58% during the forecast period (2024-2030). WealthTech Solutions Market Overview The global WealthTech Solutions Market is undergoing a transformative phase, driven by changing customer preferences, digital innovation, and evolving financial landscapes. WealthTech solutions provide digital tools and platforms that enhance operational efficiency for financial advisors, wealth
Rapid Test Market Projected to Reach USD 80.07 Billion by 2032 with 8.81% CAGR Growth
Rapid Test Market Projected to Reach USD 80.07 Billion by 2032 with 8.81% CAGR G …
Global Rapid Test Market size was valued at USD 40.75 Bn. in 2024 and the total Rapid Test Market is expected to grow by 8.81% from 2025 to 2032, reaching nearly USD 80.07 Bn. Rapid Test Market Overview The global Rapid Test Market is witnessing significant growth, driven by the increasing demand for fast, accessible diagnostic solutions across healthcare settings and home-care applications. Rapid tests are designed to detect the presence of
Agarwood Oil Market Set to Approach USD 497 Million by 2032, Driven by 5.42% CAGR Growth
Agarwood Oil Market Set to Approach USD 497 Million by 2032, Driven by 5.42% CAG …
Global Agarwood Oil Market size is expected to reach nearly US$ 496.84 Mn by 2032 with the CAGR of 5.42% during the forecast period. Agarwood Oil Market Overview Agarwood Oil, derived from the resinous wood of Aquilaria trees primarily found in Southeast Asia, is highly valued for its aromatic and therapeutic properties. Formed when the wood is infected by yeast, pests, or microbes, the oil possesses antimicrobial, antioxidant, anti-inflammatory making it widely

All 5 Releases


More Releases for Bispecific

Global Bispecific Antibody Market Size Bispecific Antibodies Clinical Trials FDA …
Global Bispecific Antibody Market, Drugs Sales, Patent, Price and Clinical Trials Insight 2029 Report Highlights: • Bispecific Antibodies Development Proprietary Platforms Insight: > 30 Platforms • Global Bispecific Antibodies Market Size Yearly and Quarterly Sales (2018 till 2023) • Global Bispecific Antibodies Market Size 2023: > USD 8 Billion • Global Bispecific Antibodies Market Forecast Till 2029 • Approved Bispecific Antibodies Yearly and Quarterly Sales (2018 till 2023) • Approved Bispecific Antibodies Regional Sales (2018 till 2023) • Clinical and Commercial Insight On Approved
Bispecific Drug Innovation - Creative Biolabs Concludes Its Journey at the 15th …
On September 5, Creative Biolabs successfully concluded its participation in the 15th Annual World Bispecific Summit. New York, USA - September 10, 2024 - The summit brought together leading experts in the bispecific antibody [https://www.creative-biolabs.com/bsab/bispecific-antibody-bsab-development-service.htm] (BsAb) field from around the globe, offering attendees a rich platform to discuss cutting-edge developments and future directions. Image: https://www.getnews.info/uploads/b7ea13d648fcb7917ba9b55571b2ba35.png In recent years, this field has grown rapidly, becoming a focal point in biopharmaceutical research and development. A
Bispecific Antibody Drug Conjugates Development
The development of bispecific antibody drug conjugates (ADCs) marks a significant advancement in the field of targeted cancer therapy. These innovative molecules combine the specificity of bispecific antibodies with the powerful cytotoxic effects of drug conjugates, creating a new class of therapeutic agents that hold great promise for treating complex and resistant cancers. The process of developing these ADCs involves intricate design, engineering, and testing to ensure their safety, efficacy,
Bispecific Antibodies: Revolutionizing Targeted Cancer Therapy
Bispecific antibodies (BsAbs) are revolutionizing targeted cancer therapy by offering a dual-targeting approach that enhances therapeutic efficacy and addresses tumor heterogeneity. These engineered antibodies are designed to recognize and bind two different antigens simultaneously, providing a more comprehensive attack on cancer cells and improving treatment outcomes. One of the most successful examples of BsAbs is blinatumomab, which targets CD19 on B-cells and CD3 on T-cells. Blinatumomab has shown remarkable efficacy in
Global Bispecific Antibody Market Research Report Forecast 2017 to 2021Global Bi …
Report Hive Market Research Released a New Research Report of 119 pages on Title " Global Bispecific Antibody Market Research Report Forecast 2017 to 2021 "with detailed Analysis, Forecast and Strategies. The Global Bispecific Antibody Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Bispecific Antibody industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as
Bispecific Antibodies Market - Global Industry Analysis 2024
Bispecific Antibodies Market Overview Bispecific antibody (BsAb) is an artificial protein that is composed of fragments of two different monoclonal antibodies and has ability to bind to two different types of antigen. Cancer immunotherapy is the most widely explored application of bispecific antibody. Lung, breast and colon cancer are the wider applications of BsAb. Bispecific antibody simultaneously binds to a cytotoxic cell and target tumor cell and destroys it. Bispecific antibodies